Peter Connelly

The Vascular Impairment of Cognition Classification Consensus Study

Olivia Anna Skrobot, John T. O’Brien, Sandra E. Black et al. · Alzheimer s & Dementia · 2016 · 224 citations · Full text

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 108 citations

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +11

Association of a salivary acetylcholinesterase with Alzheimer's disease and response to cholinesterase inhibitors

Rachel Sayer, Emma Law, Peter Connelly et al. · Clinical Biochemistry · 2003 · 93 citations

Alzheimer's Disease, Medicine, Dementia +8

A randomised double‐blind placebo‐controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease

Peter Connelly, Neil Prentice, G. Cousland et al. · International Journal of Geriatric Psychiatry · 2007 · 87 citations

A controlled trial of methylene blue in severe depressive illness

G. J. Naylor, A.H.W. Smith, Peter Connelly · Biological Psychiatry · 1987 · 76 citations

Psychiatry, Mood Symptom, Methylene Blue +7